The Great Question: Is Mydayis Available Abroad?
You’ve heard the hype—up to 16 hours of focus, extended‑release clarity, a single capsule that carries you through the entire day. But what if you’re not in the United States?
Verdict: No – Mydayis is U.S.-Only, and There’s No Plan to Change That
Mydayis was launched in the U.S. in June 2017, with FDA approval for treating ADHD in teens and adults. However, it has never been approved or sold outside the United States drugpatentwatch.com
Even in the earliest launch discussions, Shire’s leadership confirmed that no ex‑US launch was planned “for some time”, meaning they had no immediate intention to introduce Mydayis internationally insights.citeline.com. And nearly eight years later, that still stands—there are no updates pointing toward any approval or consideration for markets outside the U.S.
What People Say: Users Ask, Communities Confirm
Canada
A user in r/ADHD described moving to Canada and asking if they could still get Mydayis only to be told in 2023:
“As of 2020, couldn’t get it here.”
Another thread from 2022 confirms persistent unavailability:
“Not yet available unfortunately. I’m in the same boat…” reddit.com
UK & Europe
People in the UK have asked if they could import it or find it overseas—and the consensus is clear:
“Unfortunately my friend, Mydayis is illegal in Europe. It is the same as Adderall essentially.” pharsight.greyb.com
Other Regions
In Australia, patients have publicly lobbied Takeda to bring Mydayis to their market—with no indication from the company that a launch is in the works delta.larvol.com. Similarly, Reddit users in Lebanon and Cyprus described importing challenges and outright bans .
Why Isn’t Mydayis International?
- Regulatory & Legal Hurdles: Many countries classify amphetamines under strict schedules. Approval requires new filings, trials, and manufacturing agreements.
- Strategic Focus: Takeda and Shire have prioritized U.S. markets. Past statements indicate no active international rollout plan takeda.com.
- Market Alternatives: Other long‑acting ADHD meds (like Vyvanse/Elvanse, Concerta) already exist in other regions—perhaps making Mydayis a lower priority abroad.
What You Can Do
If you’re outside the U.S. and curious about Mydayis, here are some steps:
- Explore what’s available locally: Talk to your psychiatrist about extended-release options already approved in your country (e.g., Vyvanse/Elvanse, Concerta, Attentin).
- Advocate through professional channels: Express interest via reputable sources—patient organizations, ADHD associations, or direct to Takeda. Sometimes strong demand can shift corporate priorities.
- Consider international consultations: Some people engage U.S. telehealth doctors—though shipping controlled substances abroad is legally complicated, often restricted or blocked.
- Stay informed: Patent expiration timelines (some patents extend to 2029 abroad) may eventually open the door to generic versions in other countries pharsight.greyb.com.
Final Take
- Is Mydayis available outside the U.S.?
No. It’s not approved or sold in Canada, Europe, Australia, or most other regions. - Any signs of future availability?
No public indications. Shire/Takeda have not announced any international launch plans, and user communities continue requesting—but no approvals.
If you’re living abroad and Mydayis was a key part of your ADHD treatment, it can be frustrating. But there are effective alternative medications released internationally—you’ll need to work closely with a local provider to find the best fit.
Have you tried any long-acting ADHD meds outside the U.S.? How did they compare to Mydayis for your focus, routine, or side effects? I’d love to hear about your experience and help explore alternatives!